EAACI guideline: Anaphylaxis (2021 update)
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
EAACI guideline : Anaphylaxis (2021 update). / Muraro, Antonella; Worm, Margitta; Alviani, Cherry; Cardona, Victoria; DunnGalvin, Audrey; Garvey, Lene H.; Riggioni, Carmen; Silva, Debra de; Angier, Elizabeth; Arasi, Stefania; Bellou, Abdelouahab; Beyer, Kirsten; Bijlhout, Diola; Bilò, M. Beatrice; Bindslev-Jensen, Carsten; Brockow, Knut; Fernandez-Rivas, Montserrat; Halken, Susanne; Jensen, Britt; Khaleva, Ekaterina; Michaelis, Louise J.; Elberink, Hanneke N. G. Oude; Regent, Lynne; Sanchez, Angel; Vlieg-Boerstra, Berber J.; Roberts, Graham.
I: Allergy, Bind 77, Nr. 2, 2022, s. 357-377.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - EAACI guideline
T2 - Anaphylaxis (2021 update)
AU - Muraro, Antonella
AU - Worm, Margitta
AU - Alviani, Cherry
AU - Cardona, Victoria
AU - DunnGalvin, Audrey
AU - Garvey, Lene H.
AU - Riggioni, Carmen
AU - Silva, Debra de
AU - Angier, Elizabeth
AU - Arasi, Stefania
AU - Bellou, Abdelouahab
AU - Beyer, Kirsten
AU - Bijlhout, Diola
AU - Bilò, M. Beatrice
AU - Bindslev-Jensen, Carsten
AU - Brockow, Knut
AU - Fernandez-Rivas, Montserrat
AU - Halken, Susanne
AU - Jensen, Britt
AU - Khaleva, Ekaterina
AU - Michaelis, Louise J.
AU - Elberink, Hanneke N. G. Oude
AU - Regent, Lynne
AU - Sanchez, Angel
AU - Vlieg-Boerstra, Berber J.
AU - Roberts, Graham
PY - 2022
Y1 - 2022
N2 - Anaphylaxis is a clinical emergency which all healthcare professionals need to be able to recognize and manage. The European Academy of Allergy and Clinical Immunology Anaphylaxis multidisciplinary Task Force has updated the 2014 guideline. The guideline was developed using the AGREE II framework and the GRADE approach. The evidence was systematically reviewed and recommendations were created by weighing up benefits and harms. The guideline was peer-reviewed by external experts and reviewed in a public consultation. The use of clinical criteria to identify anaphylaxis is suggested with blood sampling for the later measurement of tryptase. The prompt use of intramuscular adrenaline as first-line management is recommended with the availability of adrenaline autoinjectors to patients in the community. Pharmacokinetic data should be provided for adrenaline autoinjector devices. Structured, comprehensive training for people at risk of anaphylaxis is recommended. Simulation training and visual prompts for healthcare professionals are suggested to improve the management of anaphylaxis. It is suggested that school policies reflect anaphylaxis guidelines. The evidence for the management of anaphylaxis remains mostly at a very low level. There is an urgent need to prioritize clinical trials with the potential to improve the management of patients at risk of anaphylaxis.
AB - Anaphylaxis is a clinical emergency which all healthcare professionals need to be able to recognize and manage. The European Academy of Allergy and Clinical Immunology Anaphylaxis multidisciplinary Task Force has updated the 2014 guideline. The guideline was developed using the AGREE II framework and the GRADE approach. The evidence was systematically reviewed and recommendations were created by weighing up benefits and harms. The guideline was peer-reviewed by external experts and reviewed in a public consultation. The use of clinical criteria to identify anaphylaxis is suggested with blood sampling for the later measurement of tryptase. The prompt use of intramuscular adrenaline as first-line management is recommended with the availability of adrenaline autoinjectors to patients in the community. Pharmacokinetic data should be provided for adrenaline autoinjector devices. Structured, comprehensive training for people at risk of anaphylaxis is recommended. Simulation training and visual prompts for healthcare professionals are suggested to improve the management of anaphylaxis. It is suggested that school policies reflect anaphylaxis guidelines. The evidence for the management of anaphylaxis remains mostly at a very low level. There is an urgent need to prioritize clinical trials with the potential to improve the management of patients at risk of anaphylaxis.
KW - adults
KW - Anaphylaxis
KW - children
KW - guidelines
U2 - 10.1111/all.15032
DO - 10.1111/all.15032
M3 - Journal article
C2 - 34343358
VL - 77
SP - 357
EP - 377
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
SN - 0105-4538
IS - 2
ER -
ID: 276668890